Long-term clinical outcome of diagnostic transurethral resection of the prostate in patients with elevated prostate-specific antigen level and minor lower urinary tract symptoms

Urologia Internationalis

Volumn 83, Issue 1, 2009, Pages 60-65

  Van Renterghem, Koenraad ^a   Van Koeveringe, Gommert ^c   Achten, Ruth ^b   Van Kerrebroeck, Philip ^c  

^a Department of Urology ^*  (Belgium)

^b VIRGA JESSE HOSPITAL   (Belgium)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Diagnostic TURP; Lower urinary tract symptoms; Prostate cancer; Prostate specific antigen; Transurethral resection of the prostate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RETROSPECTIVE STUDY; SYMPTOM; TRANSURETHRAL RESECTION;

AGED; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TRANSURETHRAL RESECTION OF PROSTATE; URINARY BLADDER NECK OBSTRUCTION;

EID: 68549115466     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000224870     Document Type: Article

References (30)

1. Kobayashi M, Nukui A, Morita T: Serum PSA and percent free PSA value changes after antibiotic treatment. A diagnostic method in prostate cancer suspects with asymptomatic prostatitis. Urol Int 2008;80:186-192.
2. Erol H, Beder N, Calişkan T, et al: Can the effect of antibiotherapy and anti-inflammatory therapy on serum PSA levels discriminate between benign and malign prostatic pathologies? Urol Int 2006;76:20-26.
3. Van Renterghem K, Van Koeveringe G, Van Kerrebroeck P: Rising PSA in patients with minor LUTS without evidence of prostatic carcinoma: a missing link? Int Urol Nephrol 2007;39:1107-1113.
4. Van Renterghem K, Van Koeveringe G, Achten R, et al: Clinical relevance of transurethral resection of the prostate in 'asymptomatic' patients with an elevated prostatespecific antigen level. Eur Urol 2007;52:819-826.
5. Durkan GC, Sheikh N, Johnson P, et al: Improving prostate cancer detection with an extended-core transrectal ultrasonographyguided prostate biopsy protocol. BJU Int 2002;89:33-39.
6. Boccon-Gibod L, van der Kwast TH, Montironi R, et al: Handling and pathology reporting of prostate biopsies. Eur Urol 2004;46:177-181.
7. Griffiths D, Hofner K, van Mastrigt R, et al: Standardization of terminology of lower urinary tract function; pressure-flow studies of voiding, urethral resistance, and urethral obstruction. International Continence Society Subcommittee on Standardization of Terminology of Pressure-Flow Studies. Neurourol Urodyn 1997;16:1-18.
8. Rosai J: Rosai and Ackerman's Surgical Pathology, ed 9. St Louis, Mosby-Year Book, 2004.
9. Katz D, Jarrard D, McHorney C, et al: Health perceptions in patients who undergo screening and workup for prostate cancer. Urology 2007;69:215-220.
10. Froehner M, Hakenberg OW, Koch R, et al: Comparison of the clinical value of complexed PSA and total PSA in the discrimination between benign prostatic hyperplasia a nd prostate Cancer. Urol Int 2006;76:27-30.
11. Catalona WJ, Southwick PC, Slawin KM, et al: Comparison of percent free PSA, PSA density and age-specific PSA cut-offs for prostate cancer detection and staging. Urology 2000;56:255-260.
12. Berger A, Deibl M, Strasak A, et al: Largescale study of clinical impact of PSA velocity: long-term PSA kinetics as method of differentiating men with from those without prostate cancer. Urology 2007;69:134-138.
13. Loeb S, Roehl KA, Catalona WJ, et al: Prostate-specific antigen velocity threshold for predicting prostate cancer in young men. J Urol 2007;177:899-902.
14. Djavan B, Ravery V, Zlotta A, et al: Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol 2001;166:1679-1683.
15. Deliveliotis C, Varkarakis J, Albanis S, et al: Biopsies of the transitional zone of the prostate. Should it be done on a routine basis, when and why? Urol Int 2002;68:113-117.
16. Rule AD, Lieber MM, Jacobsen SJ: Is benign prostatic hyperplasia a risk factor for chronic renal failure? J Urol 2005;173:691-696.
17. Section 1.2.2 of the EAU guidelines, http:// www.uroweb.org/fileadmin/ user-upload/ Guidelines/BPH.pdf.
18. 1-blockers and watchful waiting. Urology 2005;65:300-305.
19. Roehrborn CG, McConnell J, Bonilla J, et al: Serum prostate-specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study. J Urol 2000;163:13-20.
20. Rassweiler J, Teber D, Kuntz R, et al: Complications of transurethral resection of the prostate (TURP)-incidence, management and prevention. Eur Urol 2006;50:969-979.
21. Brawer MK, Lin DW, Williford WO, et al: Effect of finasteride and/or terazosin on serum PSA: results of VA Cooperative Study #359. Prostate 1999;39:234-239.
22. Madersbacher S, Marszalek M, Lackner J, et al: The long-term outcome of medical therapy for BPH. Eur Urol 2007;51:1522-1533.
23. DiSantostefano RL, Biddle AK, Lavelle JP: An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia. BJU Int 2006;97:1007-1016.
24. Teillac P, Scarpa R: Economic issues in the treatment of BPH. Eur Urol Suppl 2006;5:1018-1024.
25. Zigeuner R, Schips L, Lipsky K, et al: Detection of prostate cancer by TURP or opensurgery in patients with previously negative transrectal prostate biopsies. Urology 2003;62:883-887.
26. Ozden C, Inal G, Adsan O, et al: Detection of prostate cancer and changes in PSA six months after surgery for benign prostatic hyperplasia in patients with elevated PSA. Urol Int 2003;71:150-153.
27. Radhakrishnan S, Dorkin TJ, Sheikh N, et al: Role of transition zone sampling by TURP in patients with raised PSA and multiple negative transrectal ultrasound-guided prostatic biopsies. Prostate Cancer Prostatic Dis 2004;7:338-342.
28. Puppo P, Introini C, Calvi P, et al: Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session after repeated negative biopsies in the diagnosis of prostate cancer. Eur Urol 2006;49:873-878.
29. Reich O, Gratzke C, Stief CG: Techniques and long-term results of surgical procedures for BPH. Eur Urol 2006;49:970-978.
30. Madersbacher S, Lackner J, Brössner C, et al: Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol 2005;47:499-504.